Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP

Cisplatin (CDDP) remains a key drug for patients with advanced bladder cancer (BC), despite the emergence of new therapeutic agents; thus, the identification of factors contributing to CDDP treatment resistance is crucial. As acidity of the tumor microenvironment has been reported to be associated w...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaede Hiruma, Vladimir Bilim, Akira Kazama, Yuko Shirono, Masaki Murata, Yoshihiko Tomita
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/47/1/43
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588788613775360
author Kaede Hiruma
Vladimir Bilim
Akira Kazama
Yuko Shirono
Masaki Murata
Yoshihiko Tomita
author_facet Kaede Hiruma
Vladimir Bilim
Akira Kazama
Yuko Shirono
Masaki Murata
Yoshihiko Tomita
author_sort Kaede Hiruma
collection DOAJ
description Cisplatin (CDDP) remains a key drug for patients with advanced bladder cancer (BC), despite the emergence of new therapeutic agents; thus, the identification of factors contributing to CDDP treatment resistance is crucial. As acidity of the tumor microenvironment has been reported to be associated with treatment resistance and poor prognosis across various cancer types, our objectives in this study were to investigate the effects of an acidic environment on BC cells and elucidate the mechanisms behind CDDP resistance. Our findings show that BC cells cultured under acidic conditions developed cisplatin resistance as acidity increased. Notably, CDDP administered to BC cells in a pH 6.0 environment required double the concentration, compared to those in a pH 7.5 environment, to achieve equivalent toxicity. Using chloroquine and navitoclax, we identified the involvement of the Bcl-2 and LC3B pathways in the acquisition of CDDP resistance under acidic conditions. A Western blot analysis revealed that the activations of Bcl-2 and XIAP expression appear to inhibit both apoptotic and autophagic cell death. Taken together, these results suggest that alleviating the acidity of the tumor microenvironment in clinical settings might enhance BC sensitivity to CDDP.
format Article
id doaj-art-a671909900e2419ea08e8291bf687947
institution Kabale University
issn 1467-3037
1467-3045
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-a671909900e2419ea08e8291bf6879472025-01-24T13:27:30ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452025-01-014714310.3390/cimb47010043Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAPKaede Hiruma0Vladimir Bilim1Akira Kazama2Yuko Shirono3Masaki Murata4Yoshihiko Tomita5Department of Urology, Division of Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Urology, Division of Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Urology, Division of Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Urology, Division of Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Urology, Division of Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanDepartment of Urology, Division of Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, JapanCisplatin (CDDP) remains a key drug for patients with advanced bladder cancer (BC), despite the emergence of new therapeutic agents; thus, the identification of factors contributing to CDDP treatment resistance is crucial. As acidity of the tumor microenvironment has been reported to be associated with treatment resistance and poor prognosis across various cancer types, our objectives in this study were to investigate the effects of an acidic environment on BC cells and elucidate the mechanisms behind CDDP resistance. Our findings show that BC cells cultured under acidic conditions developed cisplatin resistance as acidity increased. Notably, CDDP administered to BC cells in a pH 6.0 environment required double the concentration, compared to those in a pH 7.5 environment, to achieve equivalent toxicity. Using chloroquine and navitoclax, we identified the involvement of the Bcl-2 and LC3B pathways in the acquisition of CDDP resistance under acidic conditions. A Western blot analysis revealed that the activations of Bcl-2 and XIAP expression appear to inhibit both apoptotic and autophagic cell death. Taken together, these results suggest that alleviating the acidity of the tumor microenvironment in clinical settings might enhance BC sensitivity to CDDP.https://www.mdpi.com/1467-3045/47/1/43potential hydrogen (pH)aciditybladder cancercisplatinBcl-2XIAP
spellingShingle Kaede Hiruma
Vladimir Bilim
Akira Kazama
Yuko Shirono
Masaki Murata
Yoshihiko Tomita
Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
Current Issues in Molecular Biology
potential hydrogen (pH)
acidity
bladder cancer
cisplatin
Bcl-2
XIAP
title Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
title_full Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
title_fullStr Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
title_full_unstemmed Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
title_short Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
title_sort acidic microenvironment enhances cisplatin resistance in bladder cancer via bcl 2 and xiap
topic potential hydrogen (pH)
acidity
bladder cancer
cisplatin
Bcl-2
XIAP
url https://www.mdpi.com/1467-3045/47/1/43
work_keys_str_mv AT kaedehiruma acidicmicroenvironmentenhancescisplatinresistanceinbladdercancerviabcl2andxiap
AT vladimirbilim acidicmicroenvironmentenhancescisplatinresistanceinbladdercancerviabcl2andxiap
AT akirakazama acidicmicroenvironmentenhancescisplatinresistanceinbladdercancerviabcl2andxiap
AT yukoshirono acidicmicroenvironmentenhancescisplatinresistanceinbladdercancerviabcl2andxiap
AT masakimurata acidicmicroenvironmentenhancescisplatinresistanceinbladdercancerviabcl2andxiap
AT yoshihikotomita acidicmicroenvironmentenhancescisplatinresistanceinbladdercancerviabcl2andxiap